Answer
Elinzanetant (Lynkuet) is indicated to treat moderate to severe vasomotor symptoms associated with menopause.
Sources for this answer
- Lynkuet 60 mg soft capsulesBayer plc · emc · SmPC §4.1 Therapeutic Indications · Version 1Document updated
Sources checked